Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5161)
All Articles published online
|
Publishing Process of This Article
|
Sep 22, 2013 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vattakatuchery JJ, Kurien R. Acetylcholinesterase inhibitors in cognitive impairment in Huntington’s disease: A brief review. World J Psychiatr 2013; 3(3): 62-64 [PMID: 24255877 DOI: 10.5498/wjp.v3.i3.62] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v3/i3/62.htm |
| Number | Citing Articles |
| 1 |
Detlef Wietelmann. Neuropsychiatrische Störungen bei Chorea Huntington. PSYCH up2date 2022; 16(06): 473 doi: 10.1055/a-1851-3700
|
| 2 |
Karen Ring, Robert O’Brien, Ningzhe Zhang, Lisa M. Ellerby. Patient-Specific Stem Cells. 2017; : 115 doi: 10.1201/9781315402185-7
|
| 3 |
Juan Manuel Orjuela-Rojas, Gustavo Adolfo Barrios Vincos, Melisa Alejandra Martínez Gallego. Neuropsiquiatría de los trastornos del movimiento. Revista Colombiana de Psiquiatría 2017; 46: 59 doi: 10.1016/j.rcp.2017.05.010
|
| 4 |
Abhijit Dey, Banadipa Nanda, Samapika Nandy, Anuradha Mukherjee, Devendra Kumar Pandey. Bioactive Natural Products. Studies in Natural Products Chemistry 2020; 67: 27 doi: 10.1016/B978-0-12-819483-6.00002-3
|
| 5 |
|
| 6 |
Abhijit Dey, Jitendra Nath De. Neuroprotective therapeutics from botanicals and phytochemicals against Huntington's disease and related neurodegenerative disorders. Journal of Herbal Medicine 2015; 5(1): 1 doi: 10.1016/j.hermed.2015.01.002
|
| 7 |
Pradeep Singh, Garima Mishra, Mulugeta Molla, Yohannes Shumet Yimer, Woretaw Sisay, Yared Andargie, Amien Ewunetie. Dietary and nutraceutical-based therapeutic approaches to combat the pathogenesis of Huntington’s disease. Journal of Functional Foods 2022; 92: 105047 doi: 10.1016/j.jff.2022.105047
|
| 8 |
Ciaran M. Considine, M. Agustina Rossetti, Kendra Anderson, Victor A. Del Bene, Sharlet A. Anderson, Andrea S. Celka, Mary C. Edmondson, Amelia L. Nelson Sheese, Adam Piccolino, Antonio L. Teixeira, Julie C. Stout. Huntington study group’s neuropsychology working group position on best practice recommendations for the clinical neuropsychological evaluation of patients with Huntington disease. The Clinical Neuropsychologist 2024; 38(4): 984 doi: 10.1080/13854046.2023.2267789
|
| 9 |
Flavia Niccolini, Marios Politis. Neuroimaging in Huntington’s disease. World Journal of Radiology 2014; 6(6): 301-312 doi: 10.4329/wjr.v6.i6.301
|
| 10 |
Sepideh Sadegh, James Skelton, Elisa Anastasi, Judith Bernett, David B. Blumenthal, Gihanna Galindez, Marisol Salgado-Albarrán, Olga Lazareva, Keith Flanagan, Simon Cockell, Cristian Nogales, Ana I. Casas, Harald H. H. W. Schmidt, Jan Baumbach, Anil Wipat, Tim Kacprowski. Network medicine for disease module identification and drug repurposing with the NeDRex platform. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-27138-2
|
| 11 |
Md. Rezaul Islam, Maruf Hossain Jony, Gazi Kaifeara Thufa, Shopnil Akash, Puja Sutra Dhar, Md. Mominur Rahman, Tahmina Afroz, Muniruddin Ahmed, Hassan A. Hemeg, Abdur Rauf, Muthu Thiruvengadam, Baskar Venkidasamy. A clinical study and future prospects for bioactive compounds and semi-synthetic molecules in the therapies for Huntington's disease. Molecular Neurobiology 2024; 61(3): 1237 doi: 10.1007/s12035-023-03604-4
|
| 12 |
Kathleen M. Shannon, Avram Fraint. Therapeutic advances in Huntington's Disease. Movement Disorders 2015; 30(11): 1539 doi: 10.1002/mds.26331
|
| 13 |
SKV Manjari, Sharon Mariam Abraham, R. Poornima, Rajneesh Kumar Chaturvedi, Shuvadeep Maity, Pragya Komal. Unprecedented effect of vitamin D3 on T-cell receptor beta subunit and alpha7 nicotinic acetylcholine receptor expression in a 3-nitropropionic acid induced mouse model of Huntington’s disease. IBRO Neuroscience Reports 2023; 15: 116 doi: 10.1016/j.ibneur.2023.07.001
|
| 14 |
Samarpita Banerjee, Champa Keeya Tudu, Samapika Nandy, Devendra K. Pandey, Mimosa Ghorai, Mahipal S. Shekhawat, Arabinda Ghosh, Potshangbam Nongdam, Abdel R. Al-Tawaha, Ercan Bursal, Gaber E-S Batiha, Suchhanda Ghosh, Vinay Kumar, Abhijit Dey. Herbal Medicines. 2022; : 37 doi: 10.1016/B978-0-323-90572-5.00010-X
|
| 15 |
Tuulia Huhtala, Pekka Poutiainen, Jussi Rytkönen, Kimmo Lehtimäki, Teija Parkkari, Iiris Kasanen, Anu J. Airaksinen, Teija Koivula, Patrick Sweeney, Outi Kontkanen, John Wityak, Celia Dominiquez, Larry C. Park. Improved synthesis of [18F] fallypride and characterization of a Huntington’s disease mouse model, zQ175DN KI, using longitudinal PET imaging of D2/D3 receptors. EJNMMI Radiopharmacy and Chemistry 2019; 4(1) doi: 10.1186/s41181-019-0071-6
|